We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 4 (1 January to 31 March 2024)
This report should be read in conjunction with the full KPI data tables…
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to April 2023 to March 2024
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 3 (1 October to 31 December 2023)
Please be aware that this data covers the time period through the COVID-19…
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to April 2022 to March 2023
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 2 (1 July to 30 September 2023)
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 1 (1 April 2022 - 30 June 2022)
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 1 (1 April 2023 - 30 June 2023)
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 4 (1 January 2023 - 31 March 2023)
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 3 (1 October 2022 - 31 December 2022)
Key Performance Indicator (KPI) data for antenatal and newborn and young person and adult screening relating to quarter 2 (1 July to 30 Sept 2024)
Key Performance Indicator (KPI) data for antenatal and newborn and young person and adult screening relating to quarter 3 (1 Oct to 31 Dec 2024)
Key Performance Indicator (KPI) data for antenatal and newborn and young person and adult screening relating to quarter 1 (1 April to 30 June 2024)
Key Performance Indicator (KPI) data for antenatal and newborn and young person and adult screening relating to quarter 1 (1 April to 30 June 2025)
Key Performance Indicator (KPI) data for antenatal and newborn and young person and adult screening relating to quarter 4 (1 Jan to 31 Mar 2025)
KPI (Key Performance Indicator) data for antenatal and newborn and young person and adult screening relating to Quarter 2 (1 July 2022 - 30 September 2022)
Data report for abdominal aortic aneurysm (AAA) screening for 1 April 2024 to 31 March 2025.
This data report presents data about standards for screening activity related to the NHS fetal anomaly screening programme (FASP).
Research on the radiation risks of digital breast screening compared with the number of lives saved.
Information on chlamydia testing and diagnoses in people aged 15 to 24 years in England by demographic characteristics and geographical region.
This report assesses the effectiveness of the NHS abdominal aortic aneurysm (AAA) screening programmes across the UK between 2013 and 2022.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).